{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:02:32Z","timestamp":1779894152258,"version":"3.53.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Randomized controlled study was conducted to evaluate the efficacy of Sanyrene\u00ae vs. control intervention (DaBao\u00ae, a complex of hyaluronic acid and Vitamin E) for acute radiation dermatitis in patients receiving radiotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with breast cancer or head and neck cancer undergoing radiotherapy (\u2265\u200950\u00a0Gy) were eligible. Participants were randomly assigned to either Sanyrene arm or control intervention arm in a ratio of 1:1. The primary endpoint was incidence rate of \u2265\u2009grade 2 radiation induced dermatitis. (Trial Registration: ChiCTR2100050910, registration date: 9\/7\/2021)<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 102 eligible patients were randomly assigned into the study. The rate of \u2265\u2009grade 2 radiation dermatitis was 22% in Sanyrene group, as compared with 67.3% in the control intervention group (<jats:italic>P<\/jats:italic>&lt;0.001). The incidence of grade 3 radiation dermatitis was 20.4% and 8.0% in control intervention group and Sanyrene group, respectively (<jats:italic>P<\/jats:italic>\u2009=\u20090.076). Patients in Sanyrene group had a longer median time to reach\u2009\u2265\u2009grade 2 radiation dermatitis compared to these in control intervention group, with hazard ratio of 0.231 (95%CI:0.116\u20130.458, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Mean score of SD-16 were much higher in control intervention group than Sanyrene group at end of radiotherapy (25 vs.8.3), 2 weeks after radiotherapy (22.9 vs. 0.5) and 4 weeks after radiotherapy (4.2 vs.0), with significantly statistical difference between two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This trial suggests that Sanyrene is effective on preventing serious radiation dermatitis and improving skin related quality of life in patients with breast cancer or head and neck cancer receiving radiotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02363-9","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:03:22Z","timestamp":1698404602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaoli","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2363_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/CCID.S94320","volume":"9","author":"M Spa\u0142ek","year":"2016","unstructured":"Spa\u0142ek M. Chronic radiation-induced dermatitis: challenges and solutions. Clin Cosmet Invest Dermatology. 2016;9:473\u201382.","journal-title":"Clin Cosmet Invest Dermatology"},{"issue":"2","key":"2363_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13555-016-0120-y","volume":"6","author":"F Bray","year":"2016","unstructured":"Bray F, Simmons B, Wolfson A, Nouri K. Acute and chronic cutaneous reactions to Ionizing Radiation Therapy. Dermatology and Therapy. 2016;6(2):185\u2013206.","journal-title":"Dermatology and Therapy"},{"key":"2363_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/jid.2011.411","volume":"132","author":"J Ryan","year":"2012","unstructured":"Ryan J. Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol. 2012;132:985\u201393.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2363_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40257-016-0186-4","volume":"17","author":"M Singh","year":"2016","unstructured":"Singh M, Alavi A, Wong R, Akita S, Radiodermatitis. A review of our current understanding. Am J Clin Dermatol. 2016;17(3):277\u201392.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"2363_CR5","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1016\/j.ijrobp.2012.05.009","volume":"84","author":"R Chan","year":"2012","unstructured":"Chan R, Larsen E, Chan P. Re-examining the evidence in radiation dermatitis management literature: an overview and a critical appraisal of systematic reviews. Int J Radiat Oncol Biol Phys. 2012;84(3):e357\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2363_CR6","doi-asserted-by":"crossref","unstructured":"Finkelstein S, Kanee L, Behroozian T, Wolf J, van den Hurk C, Chow E et al. Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Supportive care in cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2022.","DOI":"10.1007\/s00520-022-06829-6"},{"issue":"5","key":"2363_CR7","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1007\/s00520-022-06828-7","volume":"30","author":"C Lee","year":"2022","unstructured":"Lee C, Fang H, Wang C, Chou K, Huang T. Effect of hyaluronic acid on radiodermatitis in patients with Breast cancer: a meta-analysis of randomized controlled trials. Supportive care in cancer: Official Journal of the Multinational Association of Supportive Care in Cancer. 2022;30(5):3965\u201375.","journal-title":"Supportive care in cancer: Official Journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"6","key":"2363_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/00002820-200212000-00007","volume":"25","author":"S Heggie","year":"2002","unstructured":"Heggie S, Bryant G, Tripcony L, Keller J, Rose P, Glendenning M, et al. A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs. 2002;25(6):442\u201351.","journal-title":"Cancer Nurs"},{"key":"2363_CR9","doi-asserted-by":"publisher","first-page":"6559","DOI":"10.2147\/IJN.S144705","volume":"12","author":"C Yang","year":"2017","unstructured":"Yang C, Hung C, Chen B. Preparation of coffee oil-algae oil-based nanoemulsions and the study of their inhibition effect on UVA-induced skin damage in mice and Melanoma cell growth. Int J Nanomed. 2017;12:6559\u201380.","journal-title":"Int J Nanomed"},{"key":"2363_CR10","doi-asserted-by":"crossref","unstructured":"Huang TH, Wang PW, Yang SC. Cosmetic and Therapeutic Applications of Fish Oil\u2019s Fatty Acids on the Skin. 2018;16(8).","DOI":"10.3390\/md16080256"},{"issue":"2","key":"2363_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1254\/jphs.SC0070127","volume":"104","author":"S Moriyasu","year":"2007","unstructured":"Moriyasu S, Yamamoto K, Kureyama N, Okamura K, Ikeda T, Yamatodani A. Involvement of histamine released from mast cells in acute radiation dermatitis in mice. J Pharmacol Sci. 2007;104(2):187\u201390.","journal-title":"J Pharmacol Sci"},{"key":"2363_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.etap.2018.04.012","volume":"60","author":"L Su","year":"2018","unstructured":"Su L, Wang Z, Huang F, Lan R, Chen X, Han D, et al. 18\u03b2-Glycyrrhetinic acid mitigates radiation-induced skin damage via NADPH oxidase\/ROS\/p38MAPK and NF-\u03baB pathways. Environ Toxicol Pharmacol. 2018;60:82\u201390.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"2363_CR13","first-page":"9","volume":"5","author":"R Yahyapour","year":"2018","unstructured":"Yahyapour R, Amini P, Rezapour S, Cheki M, Rezaeyan A, Farhood B, et al. Radiation-induced inflammation and autoimmune Diseases. Mil Med Res. 2018;5(1):9.","journal-title":"Mil Med Res"},{"issue":"4 Suppl 1","key":"2363_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.exphem.2007.01.017","volume":"35","author":"K M\u00fcller","year":"2007","unstructured":"M\u00fcller K, Meineke V. Radiation-induced alterations in cytokine production by skin cells. Exp Hematol. 2007;35(4 Suppl 1):96\u2013104.","journal-title":"Exp Hematol"},{"issue":"3","key":"2363_CR15","first-page":"131","volume":"31","author":"P Chiari","year":"2012","unstructured":"Chiari P, Giorgi S, Ugolini D, Montanari M, Giudanella P, Gramantieri A, et al. [Randomized controlled trial on the effectiveness of Corpitolinol 60 in the prevention of pressure sores in patients undergoing Surgery]. Assist Inferm Ric. 2012;31(3):131\u20137.","journal-title":"Assist Inferm Ric"},{"issue":"2","key":"2363_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.12968\/jowc.2005.14.2.26741","volume":"14","author":"S Meaume","year":"2005","unstructured":"Meaume S, Colin D, Barrois B, Bohbot S, Allaert FA. Preventing the occurrence of pressure ulceration in hospitalised elderly patients. J Wound Care. 2005;14(2):78\u201382.","journal-title":"J Wound Care"},{"issue":"5","key":"2363_CR17","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"J Cox","year":"1995","unstructured":"Cox J, Stetz J, Pajak T. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2363_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","volume":"107","author":"M Chren","year":"1996","unstructured":"Chren M, Lasek R, Quinn L, Mostow E, Zyzanski S. Skindex, a quality-of-life measure for patients with Skin Disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707\u201313.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2363_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/120347540100500202","volume":"5","author":"M Chren","year":"2001","unstructured":"Chren M, Lasek R, Sahay A, Sands L. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with Skin Diseases. J Cutan Med Surg. 2001;5(2):105\u201310.","journal-title":"J Cutan Med Surg"},{"key":"2363_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.radonc.2019.07.014","volume":"139","author":"RJ Chan","year":"2019","unstructured":"Chan RJ, Blades R, Jones L, Downer TR, Peet SC, Button E, et al. A single-blind, randomised controlled trial of StrataXRT\u00ae - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with Head and Neck cancer. Radiother Oncol. 2019;139:72\u20138.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2363_CR21","first-page":"124","volume":"37","author":"P Vavassis","year":"2008","unstructured":"Vavassis P, Gelinas M, Chabot Tr J, Nguyen-T\u00e2n PF. Phase 2 study of silver leaf dressing for treatment of radiation-induced dermatitis in patients receiving radiotherapy to the head and neck. J Otolaryngol Head Neck Surg. 2008;37(1):124\u20139.","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"3","key":"2363_CR22","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/j.ijrobp.2012.03.062","volume":"84","author":"TM Niazi","year":"2012","unstructured":"Niazi TM, Vuong T, Azoulay L, Marijnen C, Bujko K, Nasr E, et al. Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study. Int J Radiat Oncol Biol Phys. 2012;84(3):e305\u201310.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2363_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ijrobp.2003.11.031","volume":"59","author":"T Vuong","year":"2004","unstructured":"Vuong T, Franco E, Lehnert S, Lambert C, Portelance L, Nasr E, et al. Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys. 2004;59(3):809\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2363_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clindermatol.2010.03.020","volume":"28","author":"MM McCusker","year":"2010","unstructured":"McCusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin Dermatol. 2010;28(4):440\u201351.","journal-title":"Clin Dermatol"},{"issue":"12","key":"2363_CR25","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1194\/jlr.R700013-JLR200","volume":"48","author":"KR Feingold","year":"2007","unstructured":"Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res. 2007;48(12):2531\u201346.","journal-title":"J Lipid Res"},{"issue":"4","key":"2363_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00000421-200308002-00015","volume":"26","author":"L Liang","year":"2003","unstructured":"Liang L, Hu D, Liu W, Williams JP, Okunieff P, Ding I. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary Tumor. Am J Clin Oncol. 2003;26(4):114\u201321.","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"2363_CR27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/bcp.13247","volume":"83","author":"K Schaffler","year":"2017","unstructured":"Schaffler K, Nicolas LB, Borta A, Brand T, Reitmeir P, Roebling R, et al. Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers. Br J Clin Pharmacol. 2017;83(7):1424\u201335.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2363_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1871523017666180411162114","volume":"17","author":"A Ghasemi","year":"2018","unstructured":"Ghasemi A, Danesh B, Yazdani-Charati J, Hosseinimehr SJ. Randomized double-blind placebo-controlled trial of Celecoxib for the Prevention of skin toxicity in patients receiving Radiation therapy for Breast Cancer. Antiinflamm Antiallergy Agents Med Chem. 2018;17(1):57\u201367.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"issue":"3","key":"2363_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0167-8140(01)00327-9","volume":"59","author":"A Bostr\u00f6m","year":"2001","unstructured":"Bostr\u00f6m A, Lindman H, Swartling C, Berne B, Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2001;59(3):257\u201365.","journal-title":"Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"2","key":"2363_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ijrobp.2018.02.006","volume":"101","author":"A Ho","year":"2018","unstructured":"Ho A, Olm-Shipman M, Zhang Z, Siu C, Wilgucki M, Phung A, et al. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer patients receiving Postmastectomy Radiation. Int J Radiat Oncol Biol Phys. 2018;101(2):325\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2363_CR31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ijrobp.2010.01.031","volume":"79","author":"R Miller","year":"2011","unstructured":"Miller R, Schwartz D, Sloan J, Griffin P, Deming R, Anders J, et al. Mometasone furoate effect on acute skin toxicity in Breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011;79(5):1460\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2363_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40264-015-0287-7","volume":"38","author":"L Barnes","year":"2015","unstructured":"Barnes L, Kaya G, Rollason V. Topical corticosteroid-induced skin atrophy: a comprehensive review. Drug Saf. 2015;38(5):493\u2013509.","journal-title":"Drug Saf"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02363-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02363-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02363-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:06:49Z","timestamp":1698404809000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02363-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2363"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02363-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Air Force Medical University (ethical approval number: KY20202016-F-1). Written informed consent was obtained from participants to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"174"}}